Supplements
curcumin decreases osteoarthritis pain
In plain terms: Does turmeric help arthritis and joint pain?
Strong support Supplements 🔬 Includes disconfirming
Part of: 🧪 turmeric & curcumin
RefutedContestedStrong support
consensus score 0.93
Yes — this is curcumin's strongest claim. Multiple meta-analyses find standardized curcumin extract eases knee-osteoarthritis pain about as well as anti-inflammatory drugs over the short term. Note that's supplement doses, not turmeric sprinkled on food.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
18 support 0 contradict 3 tested null 2 mixed · 23 sources, 17 independent groups
What the evidence shows
Curcumin's best-supported human claim. Multiple independent meta-analyses of RCTs find standardized curcumin/turmeric extract (~1000 mg/day) reduces knee-osteoarthritis pain and improves function, roughly comparable to NSAIDs over short-term use — though trials are mostly short and use bioavailability-enhanced formulations, not dietary turmeric.
The evidence (23)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Chen J et al 2025 · study_type: observational | meta-analysis | supports | low | Critical review of 7 systematic reviews/meta-analyses on curcumin for knee OA (AMSTAR2/PRISMA/ROBIS/GRADE assessed); found curcumin showed potential efficacy/safety advantages over control, but underlying SRs were of 'extremely low methodol |
| Toumi H et al 2026 · study_type: observational | observational | supports | moderate | Narrative review of 165 studies on curcumin in arthritis; states clinical evidence in OA indicates improvements in pain/function, efficacy sometimes comparable to NSAIDs, but calls evidence 'limited' and cautions on bioavailability/formulat |
| Raja K et al 2026 · study_type: in-vitro | in-vitro | supports | low | In-vitro human BMSC-derived chondrocyte model with LPS-induced OA-like injury; curcumin (25-100uM) restored mitochondrial membrane potential, increased autophagy markers (Beclin-1, LC3-II), and reduced apoptotic signaling. |
| Lopresti AL et al 2026 · study_type: RCT | RCT | supports | moderate | RCT, n=60 adults with knee OA, topical curcumin gel (VAS-101) vs placebo gel over 28 days; KOOS pain score improved (beta 5.12, 95%CI 0.47-9.77, d=0.62, p=0.041) and daily pain ratings improved (p=0.005) vs placebo. |
| Bideshki 2024 · Phytother Res | meta-analysis | supports | high | Umbrella meta-analysis of meta-analyses: curcumin improves knee-OA pain and function, despite between-review heterogeneity. |
| Lan CW et al 2026 · study_type: animal | animal | tested-null | low | Rat MIA-induced knee OA model; turmeric fermentation liquid reduced inflammatory cytokines (TNF-a, IL-1b), increased IL-10, and reduced pain behavior and cartilage degradation vs MIA control. |
| Liu 2018 · Br J Sports Med | meta-analysis | supports | high | Network meta-analysis (Br J Sports Med): curcumin among the dietary supplements effective for OA pain and function. |
| Wai HS et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | Systematic review + network meta-analysis of 17 RCTs on turmeric products for knee OA; all turmeric preparations significantly reduced WOMAC pain vs placebo (bioavailability-enhanced formulation MD -2.47, 95%CI -3.27 to -1.67, reaching MCID |
| Daily 2016 · J Med Food | meta-analysis | supports | moderate | SR+meta-analysis of RCTs: turmeric/curcumin extracts (~1000 mg/day) reduced arthritis pain, most consistently in knee OA. |
| Zeng 2022 · Front Immunol | meta-analysis | supports | moderate | SR+meta-analysis of RCTs: curcumin improved OA pain, stiffness and physical function. |
| Jhun J et al 2025 · study_type: animal | animal | supports | low | Rat MIA-induced OA model; curcumin plus omega-3 reduced pain behavior (paw withdrawal latency/threshold, weight bearing) and cartilage damage (Mankin score) vs vehicle, comparable direction to celecoxib. |
| Balcı EC et al 2026 · study_type: animal | animal | tested-null | low | Rat distal femoral osteochondral defect model; oral micellar curcumin (250 mg/kg/day) improved macroscopic/histological repair scores and cartilage markers (SOX9, collagen II, aggrecan) vs control at 90 days; no pain outcome directly measur |
| Patel M et al 2026 · study_type: observational | observational | supports | moderate | Narrative review synthesizing preclinical/translational/clinical evidence on nutritional interventions for OA; states curcumin and other bioactives show anti-inflammatory/antioxidant/chondroprotective effects via NF-kB/Nrf2/AMPK/SIRT1, fram |
| Shelton T et al 2025 · study_type: observational | observational | supports | moderate | Scoping narrative review of curcumin/turmeric across pain-medicine conditions; concludes most clinical research is in knee OA and reports 'efficacy of turmeric in pain control of knee osteoarthritis,' but calls for more research in other pa |
| Wang S et al 2026 · study_type: animal | animal | supports | low | In vitro + in vivo (rat) study; curcumin-modified magnesium hydroxide microspheres (Cur-Mg/PLGA) alleviated OA-associated pain, suppressed osteoclast activation, and preserved cartilage matrix in an OA model. |
| Dai N et al 2026 · study_type: mechanism | animal | supports | low | Mouse OA model + in-vitro chondrocytes; curcumin elevated miR-338-3p, suppressed EIF4A1, reduced chondrocyte apoptosis/inflammatory cytokines (IL-6, TNF-a, IL-1b) and improved OARSI scores. |
| Shi C et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | Umbrella review of 10 meta-analyses/SRs on curcumin formulations for OA; found significant improvements in VAS pain and WOMAC function, efficacy signals comparable to NSAIDs with better tolerability, but only 3/10 rated high quality on AMST |
| Zeng 2021 · Biosci Rep | meta-analysis | supports | high | SR+meta-analysis: Curcuma longa/curcumin reduced OA pain and improved function, comparable to NSAIDs short-term, with fewer GI adverse events. |
| Zhou Y et al 2025 · study_type: animal | animal | supports | low | In vivo rat OA model; thermosensitive curcumin-loaded hydrogel (Cur@HBC) reduced cartilage degradation, MMP13/inflammatory cytokines, and promoted M2 macrophage polarization vs control. |
| Park HS et al 2026 · study_type: animal | animal | supports | moderate | Rat MIA-induced OA model; curcuminoids phospholipid (CP) improved pain-related weight-bearing behavior and cartilage integrity vs MIA control, comparable direction to celecoxib positive control. |
| Hridayanka KSN et al 2025 · study_type: animal | animal | mixed | low | Rat MIA-induced knee OA model; intra-articular nanoemulsified curcumin (n-Cur) reduced joint edema, joint-space narrowing, cartilage fibrillation, and synovial macrophage recruitment vs untreated OA knees. |
| Tuntiyatorn P et al 2025 · study_type: RCT | RCT | tested-null | low | Pilot double-blind RCT, n=27 (13 curcumin 170mg/day vs 14 placebo) hand OA over 3 months; curcumin group showed significant VAS pain reduction (mean diff 1.37, p=0.032 at rest; 1.74, p=0.017 activity) and DASH score improvement (11.84, p=0. |
| Park D et al 2026 · study_type: observational | observational | mixed | moderate | Structured narrative review (no meta-analysis) of nutraceuticals incl. curcumin for knee OA with sarcopenia; symptomatic benefits across curcumin/glucosamine/Boswellia/omega-3/collagen described as 'modest, heterogeneous, and formulation-de |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.